LENSAR Retained Earnings (Accumulated Deficit) 2019-2024 | LNSR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

LENSAR retained earnings (accumulated deficit) from 2019 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

LENSAR Retained Earnings (Accumulated Deficit) 2019-2024 | LNSR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

LENSAR retained earnings (accumulated deficit) from 2019 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$194.7B
Intuitive Surgical (ISRG)	$191.9B
Alcon (ALC)	$42.1B
Edwards Lifesciences (EW)	$41.4B
IQVIA Holdings (IQV)	$34.7B
IDEXX Laboratories (IDXX)	$34.1B
DexCom (DXCM)	$29.2B
STERIS (STE)	$20.9B
Waters (WAT)	$20.5B
SONOVA HOLDING (SONVY)	$20.3B
Hologic (HOLX)	$18.2B
Fresenius Medical Care AG KGaA (FMS)	$13B
Sysmex ADR (SSMXY)	$12.7B
Globus Medical (GMED)	$11.3B
Penumbra (PEN)	$9.1B
Teleflex (TFX)	$9B
Masimo (MASI)	$8.8B
Glaukos (GKOS)	$8B
PROCEPT BioRobotics (PRCT)	$4.9B
Integer Holdings (ITGR)	$4.5B
Veracyte (VCYT)	$3B
Inari Medical (NARI)	$3B
LivaNova (LIVN)	$2.8B
TransMedics (TMDX)	$2.8B
Nihon Kohden (NHNKY)	$2.3B
Elekta AB (EKTAY)	$2.2B
Tandem Diabetes Care (TNDM)	$1.8B
RxSight (RXST)	$1.8B
Integra LifeSciences Holdings (IART)	$1.8B
Alphatec Holdings (ATEC)	$1.4B